[HTML][HTML] Role of structural and non-structural proteins and therapeutic targets of SARS-CoV-2 for COVID-19
Coronavirus belongs to the family of Coronaviridae, comprising single-stranded, positive-
sense RNA genome (+ ssRNA) of around 26 to 32 kilobases, and has been known to cause …
sense RNA genome (+ ssRNA) of around 26 to 32 kilobases, and has been known to cause …
[HTML][HTML] In vivo structural characterization of the SARS-CoV-2 RNA genome identifies host proteins vulnerable to repurposed drugs
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the ongoing
coronavirus disease 2019 (COVID-19) pandemic. Understanding of the RNA virus and its …
coronavirus disease 2019 (COVID-19) pandemic. Understanding of the RNA virus and its …
SARS-CoV-2: insight in genome structure, pathogenesis and viral receptor binding analysis–an updated review
The novel coronavirus disease (COVID-19) a global pandemic outbreak is an emerging new
virus accountable for respiratory illness caused by SARS-CoV-2, originated in Wuhan city …
virus accountable for respiratory illness caused by SARS-CoV-2, originated in Wuhan city …
The novel insight of SARS-CoV-2 molecular biology and pathogenesis and therapeutic options
On December 31, 2019, a novel coronavirus, being the third highly infective CoV and named
as coronavirus disease 2019 (COVID-19) in the city of Wuhan, was announced by the World …
as coronavirus disease 2019 (COVID-19) in the city of Wuhan, was announced by the World …
[HTML][HTML] SARS-CoV-2: from its discovery to genome structure, transcription, and replication
SARS-CoV-2 is an extremely contagious respiratory virus causing adult atypical pneumonia
COVID-19 with severe acute respiratory syndrome (SARS). SARS-CoV-2 has a single …
COVID-19 with severe acute respiratory syndrome (SARS). SARS-CoV-2 has a single …
[HTML][HTML] Structural biology of SARS-CoV-2 and implications for therapeutic development
H Yang, Z Rao - Nature Reviews Microbiology, 2021 - nature.com
The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), is an unprecedented global health crisis. However, therapeutic options for …
(SARS-CoV-2), is an unprecedented global health crisis. However, therapeutic options for …
[HTML][HTML] Comprehensive in vivo secondary structure of the SARS-CoV-2 genome reveals novel regulatory motifs and mechanisms
Summary Severe-acute-respiratory-syndrome-related coronavirus 2 (SARS-CoV-2) is the
positive-sense RNA virus that causes coronavirus disease 2019 (COVID-19). The genome …
positive-sense RNA virus that causes coronavirus disease 2019 (COVID-19). The genome …
Potential drug targets of SARS-CoV-2: From genomics to therapeutics
The emergence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) from
China has become a global threat due to the continuous rise in cases of Coronavirus …
China has become a global threat due to the continuous rise in cases of Coronavirus …
[HTML][HTML] Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases
S Kakavandi, I Zare, M VaezJalali, M Dadashi… - Cell Communication and …, 2023 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is caused by a new member of the
Coronaviridae family known as severe acute respiratory syndrome coronavirus 2 (SARS …
Coronaviridae family known as severe acute respiratory syndrome coronavirus 2 (SARS …
[HTML][HTML] Insights into COVID-19 vaccine development based on immunogenic structural proteins of SARS-CoV-2, host immune responses, and herd immunity
The first quarter of the 21st century has remarkably been characterized by a multitude of
challenges confronting human society as a whole in terms of several outbreaks of infectious …
challenges confronting human society as a whole in terms of several outbreaks of infectious …
相关搜索
- sars cov genome structure
- sars cov therapeutic targets
- covid 19 therapeutic targets
- sars cov covid 19
- sars cov host proteins
- sars cov vaccine development
- sars cov repurposed drugs
- sars cov molecular biology
- therapeutic development structural biology
- sars cov prevention of progression
- sars cov herd immunity
- sars cov therapeutic development
- sars cov drug targets
- sars cov structural biology
- sars cov therapeutic options
- sars cov rna genome